This Justification (J&A) opportunity from Department Of Health And Human Services was posted on August 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Leptin Protein (26-006897)

Awarded

26-006897Federal

Submission Closed08/26/2026, 12:00:00 PM EDT

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

Federal

Biological Feedstock SupplyThis subcontract with the Defense Advanced Research Projects Agency involves the supply of raw biological feedstocks to support prime contractors working on protein purification projects. The scope of work requires the generation and delivery of complex mixtures of soluble and insoluble components, specifically bacterial, yeast, and mammalian cell lysates designed to simulate standard biomanufacturing environments. All deliverables must consist of quantified volumes of feedstock accompanied by detailed documentation of their composition. Compliance with Biosafety Level certifications is mandatory and will be determined based on the specific type of feedstock provided. Interested parties should note that the response deadline for this opportunity is January 22, 2027, and the work falls under NAICS code 325414.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

ANTIVENIN, SNAKE VENOM, PAN-AFRICA

Solicitation # SPE2DP-27-Q-0009

This solicitation, SPE2DP-27-Q-0009, is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Pan-Africa polyvalent F(ab)2 immunoglobulin fragments (equine) antivenin. The product is designed to treat snakebite envenomation caused by 25 different species from the Viperidae, Elapidae, Colubridae, and Atractaspididae families. The requirement is for 6 cases, with each case containing 36 vials (6 vials per box, 6 boxes per case). The item is a Type I (Code Q) item with a non-extendable shelf life of 36 months and must be stored at room temperature. The contract is a firm fixed price agreement with delivery required 15 days after order. Shipping is FOB Destination, and the material must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage, with palletization following RP001 DLA Packaging Requirements and MIL-STD-2073-1E. Payment and receiving reports must be processed electronically via the Wide Area WorkFlow (WAWF) system. The procurement incorporates various FAR and DFARS clauses, including requirements for cybersecurity safeguarding, anti-terrorism awareness, and the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Trivalent Seasonal Influenza Vaccine Production (SH 2027)This subcontract involves the manufacture and supply of trivalent Seasonal Influenza Virus Vaccines for the Southern Hemisphere 2027 season to support prime contractors fulfilling UNICEF supply contracts. The selected provider is responsible for the entire production cycle, including bulk production, formulation, filling, and labeling. Acceptable manufacturing methods include egg-based, cell culture, recombinant protein, or nucleic acid-based processes, provided the facility possesses the necessary bioreactors or egg-incubation infrastructure and maintains WHO Pre-qualification. The scope of delivery requires the provision of 2,250 10-dose vials and 100 1-dose vials. Performance for this contract will take place across multiple destinations to meet the distribution needs of the agency. The opportunity was posted on November 9, 2026, under NAICS code 325414.

POSTED

DEADLINE

Seasonal Influenza Virus Vaccine, Southern Hemisphere Influenza Season 2027 Luis Roberto Mena - [email hidden]

Solicitation # RFP-DAN-2026-503974

UNICEF is soliciting proposals under RFP-DAN-2026-503974 for the supply of WHO pre-qualified 2027 Southern Hemisphere seasonal influenza vaccines. The objective is to secure quality supplies for the earliest possible delivery in 2027 to meet forecasted demand. Vaccines must meet specific composition requirements for H1N1, H3N2, and B/Victoria lineage strains. Pricing must be quoted based on INCOTERMS 2020 FCA at the nearest international airport, with standard payment terms of net 30 days via bank transfer. Bidders must be registered in the United Nations Global Marketplace and submit a proposal consisting of separate technical and commercial volumes. Technical evaluation is conducted in collaboration with the WHO, focusing on WHO pre-qualification, delivery lead times, and proven past performance. Strict packaging and labeling standards are required, including compliance with WHO Guidelines on the International Packaging and Shipping of Vaccines and mandatory GS1-barcoding on secondary packaging. Suppliers are responsible for the classification of dangerous goods and must provide all necessary Material Safety Data Sheets.

POSTED

DEADLINE

ITB- Supply and delivery of AHS veterinary vaccines [email hidden]

Solicitation # 2026/FNSDN/FNSDN/138908

The Food and Agriculture Organization of the United Nations (FAO) is soliciting offers for the supply and delivery of AHS veterinary vaccines to be delivered to Chad. This solicitation, identified as 2026/FNSDN/FNSDN/138908, is managed by the FAO procurement team in Sudan and falls under NAICS code 325414. Interested bidders must possess at least a UNGM Basic Registration to participate in the procurement process. All offers must be submitted exclusively through the United Nations Global Marketplace (UNGM) portal, as any submissions made outside of this system will be invalidated. The submission process requires a structured approach using a technical offer, a financial offer, and a mandatory questionnaire where all yellow-highlighted fields must be completed. Bidders are advised to keep file sizes under 5MB and avoid using special characters in filenames to prevent document corruption. All official correspondence regarding the tender must be conducted through the correspondence tab of the UNGM portal.

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0004

Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0003

Solicitation SPE2DP26R0003 is a request for Injectable Influenza Vaccine 2027 issued by the Department of Defense through DLA Troop Support, based in Philadelphia, Pennsylvania. This procurement falls under NAICS code 325414. The solicitation was posted on November 4, 2026, with a response deadline of December 3, 2026, at 8:00 PM. Primary contact for this effort is Rosbert Jones, with Melissa Rios Thomas serving as the secondary point of contact. Proposals must be submitted electronically via the DIBBS system in accordance with FAR 15.208(a). Submissions are subject to strict technical requirements, including a maximum file size of 10 MB per document and a 60-character limit for file names. File names must not contain spaces and may only use hyphens or underscores as special characters. Acceptable file formats include standard document, image, and spreadsheet extensions such as .pdf, .docx, and .xlsx.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Scalable Biologic Manufacturing and FormulationThis subcontract focuses on the development of CMC strategies and scalable production processes for biologic therapies supporting prime contractors on NIH/NINDS projects. The scope of work involves utilizing bioreactors and cleanroom facilities to establish manufacturing processes and formulation strategies, ensuring that all quality attributes are validated in accordance with GMP and regulatory standards for clinical application. The successful provider will be responsible for delivering comprehensive scalable manufacturing documentation, formulated drug products, and detailed quality specifications. This effort is managed under the National Institutes of Health within the Department of Health and Human Services, falling under NAICS code 325414 for biologic product manufacturing.

National Institutes Of Health

POSTED

DEADLINE

Vaccination Campaigns - Procurement of Animal Vaccines.

Solicitation # GC3G2C

The Council for Development and Reconstruction is seeking solicitations for the procurement of animal vaccines to support vaccination campaigns within Lebanon. This federal initiative is managed by the Funding Division, with Oussama Kobeissi serving as the primary point of contact for interested parties. The solicitation, identified by number GC3G2C, was posted on October 22, 2026, and requires responses to be submitted by the deadline of December 3, 2026. All performance of the contract will take place in Lebanon.

Council for Development and Reconstruction

POSTED

DEADLINE

Antithrombin III Procurement

Solicitation # CBP-CON-00260

The National Blood Authority is seeking tenders for the procurement of an Antithrombin III product under solicitation number CBP-CON-00260. While the agency currently maintains supply arrangements for Thrombotrol through the National Fractionation Agreement for Australia, this request for tender opens the process for the provision of these essential medical supplies. Interested parties must submit their responses by the deadline of November 20, 2026. All inquiries and submissions should be directed to the CBP Procurement Team via the provided contact email. Further detailed specifications and requirements are contained within the official request for tender documentation.

National Blood Authority

POSTED

DEADLINE

Proteomics and Protein Expression AnalysisThe Proteomics and Protein Expression Analysis subcontract supports National Institutes of Health projects focused on identifying biomarkers related to substance exposure and brain development. The selected provider will perform protein identification and quantification for prime contractors using a variety of high-sensitivity methods, including mass spectrometry, ELISA, Western blotting, and protein-protein interaction assays via LC-MS/MS. To ensure the integrity of the results, the performing laboratory must adhere to ISO/IEC 17025 quality standards. The primary deliverables for this engagement consist of detailed quantitative biomarker reports and comprehensive protein expression profiles. This effort falls under NAICS code 325414 and is managed through the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

3 months ago

DEADLINE

N/A

AI Contract Overview

The National Institute of Health intends to award a firm-fixed-price purchase order to BIO-TECHNE SALES CORP. for the procurement of Recombinant Rat Leptin Protein. This requirement is being handled as a sole-source procurement without full and open competition because the product is manufactured directly by the supplier. The material is specifically required for in vivo experiments under the ORWH Innovation Awards focusing on sex- and obesity-associated mechanisms and therapeutic targets in pulmonary arterial hypertension. The NIH has determined that BIO-TECHNE SALES CORP. is the only capable provider, as changing the biological material would necessitate costly additional testing and validation, preventing the comparison of in vivo results. The procurement supports the Critical Care Medicine Department within the NIH Clinical Center, which conducts extensive research in bedside clinical investigation, animal models, and molecular biology. The department's research interests include the immunopathogenesis of septic shock, respiratory distress syndrome, pulmonary arterial hypertension, and various infectious diseases. This specific acquisition falls under NAICS code 325414 and is managed by the Department of Health and Human Services. The solicitation is identified by number 26-006897, with a response deadline of August 26, 2026.

General Info

NIH awards Bio-Techne Sales Corp a sole-source order for Recombinant Rat Leptin Protein.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Bethesda, MD, 20817, USA

Set-Aside

NONE

Documents

8 pages · justification-and-authorization

High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 19

special-notice

AwardedNov 15

Contract was awarded

Submission Closed

08/26/2026, 12:00:00 PM EDT

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

Gregory Noland

Full Description

The National Institute of Health (NIH) intends to negotiate and award a purchase order without
providing for full and open competition to BIO-TECHNE SALES CORP. The purpose of this requirement is to provide a firm-fixed-price contract for Recombinant Rat Leptin Protein in the Critical Care Medicine Department within the NIH Clinical Center.

The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology.

Full-time research activities commence at the beginning of the second year of the fellowship for fellows interested in the critical care subspecialty alone. For those interested in dual board eligibility, their second-year program is individually designed and consists of clinical rotations required for board eligibility in the particular subspecialties. After completion of second subspecialty training, full-time research activities commence. Major topics of research interest within the Department include:

The immunopathogenesis of septic shock
Studies of immune cellular function in respiratory distress syndrome, asthma, and other forms of severe pulmonary disease
Biomarkers and novel therapies in pulmonary arterial hypertension
Biomarkers of acute cellular rejection in heart transplantation
Diagnosis and treatment of opportunistic infections
Studies of immune cellular function and therapy of AIDS
Pathogenesis and treatment of anthrax
Emerging infectious diseases
Biology and clinical effects of nitric oxide
- acute lung injury
- pulmonary arterial hypertension
- role as transcription regulatory factor
Functional genomics of critical illness
- human acute inflammation
- animal model of septic shock and multiple organ failure
- pulmonary arterial hypertension
- solid organ transplantation
- Emerging Infectious Disease

This product is a sole source item as it’s manufactured by the supplier. This material will be use on in vivo experiment under ORWH Innovation Awards SEX- AND OBESITY-ASSOCIATED MECHANISMS AND THERAPEUTIC TARGETS IN PULMONARY ARTERIAL HYPERTENSION. Biological material for animal treatments can’t be changed as we will incur in additional testing, additional testing subjects and validation and in vivo results can’t be compared.

Finally, a review of the GSA Advantage, Dynamic Small Business Search, and previous government acquisitions returned no results that meet all of the requirements. Therefore, only BIO-TECHNE SALES CORP. is capable of meeting the needs of this requirement.